Table 2 |
|||||||
|
Correlations between serum levels of resistin and disease activity in patients with inflammatory myopathies. |
|||||||
|
IIM |
Myositis |
DM |
|||||
|
Parameter |
Correlation |
all |
Jo-1 + |
Jo-1- |
pure |
overlap |
|
|
|
|||||||
|
MYOACT |
r |
0.382 |
0.789 |
0.283 |
0.866 |
0.387 |
0.667 |
|
p |
0.026 |
0.007 |
0.181 |
0.33 |
0.125 |
0.001 |
|
|
MMT8 |
r |
-0.055 |
-0.179 |
0.002 |
-0.400 |
0.020 |
-0.439 |
|
p |
0.765 |
0.632 |
0.993 |
0.750 |
0.944 |
0.134 |
|
|
Myoglobin |
r |
0.233 |
0.650 |
0.114 |
0.200 |
0.079 |
0.791 |
|
p |
0.159 |
0.067 |
0.490 |
0.917 |
0.794 |
0.0003 |
|
|
CK |
r |
0.145 |
0.417 |
0.122 |
0.200 |
-0.110 |
0.739 |
|
p |
0.385 |
0.270 |
0.528 |
0.917 |
0.663 |
0.001 |
|
|
CRP |
r |
0.328 |
0.717 |
0.14 |
-0.800 |
0.511 |
0.447 |
|
p |
0.044 |
0.037 |
0.469 |
0.333 |
0.030 |
0.067 |
|
|
|
|||||||
|
Abbreviations: CK, creatine kinase; CRP, C-reactive protein; DM, dermatomyositis; IIM, inflammatory myopathies; Jo-1, anti-Jo-1 antibody; MYOACT, disease activity assessment visual analogue scales |
|||||||
|
Filková et al. Arthritis Research & Therapy 2012 14:R111 doi:10.1186/ar3836 |
|||||||
